Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

Similar articles for PubMed (Select 21925840)

1.

Increased neurokinin-1 receptor availability in temporal lobe epilepsy: a positron emission tomography study using [(11)C]GR205171.

Danfors T, Åhs F, Appel L, Linnman C, Fredrikson M, Furmark T, Kumlien E.

Epilepsy Res. 2011 Nov;97(1-2):183-9. doi: 10.1016/j.eplepsyres.2011.08.006. Epub 2011 Sep 16.

PMID:
21925840
2.

Age, sex and NK1 receptors in the human brain -- a positron emission tomography study with [¹¹C]GR205171.

Engman J, Åhs F, Furmark T, Linnman C, Pissiota A, Appel L, Frans Ö, Långström B, Fredrikson M.

Eur Neuropsychopharmacol. 2012 Aug;22(8):562-8. doi: 10.1016/j.euroneuro.2011.12.005. Epub 2012 Jan 4.

PMID:
22225860
3.

Synthesis of two potential NK1-receptor ligands using [1-11C]ethyl iodide and [1-11C]propyl iodide and initial PET-imaging.

Syvänen S, Eriksson J, Genchel T, Lindhe O, Antoni G, Långström B.

BMC Med Imaging. 2007 Jul 30;7:6.

4.

Differential features of metabolic abnormalities between medial and lateral temporal lobe epilepsy: quantitative analysis of (18)F-FDG PET using SPM.

Kim YK, Lee DS, Lee SK, Kim SK, Chung CK, Chang KH, Choi KY, Chung JK, Lee MC.

J Nucl Med. 2003 Jul;44(7):1006-12.

5.

NMDA-receptor activity visualized with (S)-[N-methyl-11C]ketamine and positron emission tomography in patients with medial temporal lobe epilepsy.

Kumlien E, Hartvig P, Valind S, Oye I, Tedroff J, Långström B.

Epilepsia. 1999 Jan;40(1):30-7.

PMID:
9924899
6.

Symptom provocation in specific phobia affects the substance P neurokinin-1 receptor system.

Michelgård A, Appel L, Pissiota A, Frans O, Långström B, Bergström M, Fredrikson M.

Biol Psychiatry. 2007 Apr 15;61(8):1002-6. Epub 2006 Sep 1.

PMID:
16950220
7.

Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo.

Furmark T, Appel L, Michelgård A, Wahlstedt K, Ahs F, Zancan S, Jacobsson E, Flyckt K, Grohp M, Bergström M, Pich EM, Nilsson LG, Bani M, Långström B, Fredrikson M.

Biol Psychiatry. 2005 Jul 15;58(2):132-42.

PMID:
16038684
8.

In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis.

Goffin K, Van Paesschen W, Van Laere K.

Brain. 2011 Apr;134(Pt 4):1033-40. doi: 10.1093/brain/awq385. Epub 2011 Feb 8.

9.

Changes in central 5-HT(1A) receptor binding in mesial temporal epilepsy measured by positron emission tomography with [(11)C]WAY100635.

Ito S, Suhara T, Ito H, Yasuno F, Ichimiya T, Takano A, Maehara T, Matsuura M, Okubo Y.

Epilepsy Res. 2007 Jan;73(1):111-8. Epub 2006 Nov 9.

PMID:
17097271
10.

Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET study.

Werhahn KJ, Landvogt C, Klimpe S, Buchholz HG, Yakushev I, Siessmeier T, Müller-Forell W, Piel M, Rösch F, Glaser M, Schreckenberger M, Bartenstein P.

Epilepsia. 2006 Aug;47(8):1392-6.

PMID:
16922886
11.

Epilepsy duration impacts on brain glucose metabolism in temporal lobe epilepsy: results of voxel-based mapping.

Akman CI, Ichise M, Olsavsky A, Tikofsky RS, Van Heertum RL, Gilliam F.

Epilepsy Behav. 2010 Mar;17(3):373-80. doi: 10.1016/j.yebeh.2009.12.007. Epub 2010 Feb 10.

PMID:
20149754
12.

Quantitative analysis of NK1 receptor in the human brain using PET with 18F-FE-SPA-RQ.

Okumura M, Arakawa R, Ito H, Seki C, Takahashi H, Takano H, Haneda E, Nakao R, Suzuki H, Suzuki K, Okubo Y, Suhara T.

J Nucl Med. 2008 Nov;49(11):1749-55. doi: 10.2967/jnumed.108.054353. Epub 2008 Oct 16.

13.

Correlation of temporal lobe glucose metabolism with the Wada memory test.

Hong SB, Roh SY, Kim SE, Seo DW.

Epilepsia. 2000 Dec;41(12):1554-9.

PMID:
11114213
14.

Gender and age affect NK1 receptors in the human brain - a positron emission tomography study with [18F]SPA-RQ.

Nyman MJ, Eskola O, Kajander J, Vahlberg T, Sanabria S, Burns D, Hargreaves R, Solin O, Hietala J.

Int J Neuropsychopharmacol. 2007 Apr;10(2):219-29. Epub 2006 Mar 30.

PMID:
16573846
15.

Insular cortex involvement in mesiotemporal lobe epilepsy: a positron emission tomography study.

Bouilleret V, Dupont S, Spelle L, Baulac M, Samson Y, Semah F.

Ann Neurol. 2002 Feb;51(2):202-8.

PMID:
11835376
16.
17.

Postoperative alteration of cerebral glucose metabolism in mesial temporal lobe epilepsy.

Joo EY, Hong SB, Han HJ, Tae WS, Kim JH, Han SJ, Seo DW, Lee KH, Hong SC, Lee M, Kim S, Kim BT.

Brain. 2005 Aug;128(Pt 8):1802-10. Epub 2005 May 4.

18.

Sequential 123I-iododexetimide scans in temporal lobe epilepsy: comparison with neuroimaging scans (MR imaging and 18F-FDG PET imaging).

Mohamed A, Eberl S, Fulham MJ, Kassiou M, Zaman A, Henderson D, Beveridge S, Constable C, Lo SK.

Eur J Nucl Med Mol Imaging. 2005 Feb;32(2):180-5. Epub 2004 Sep 23.

PMID:
15449046
19.

Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI.

Hammers A, Koepp MJ, Hurlemann R, Thom M, Richardson MP, Brooks DJ, Duncan JS.

Brain. 2002 Oct;125(Pt 10):2257-71.

20.

Temporal hypometabolism at the onset of cryptogenic temporal lobe epilepsy.

Matheja P, Kuwert T, Lüdemann P, Weckesser M, Kellinghaus C, Schuierer G, Diehl B, Ringelstein EB, Schober O.

Eur J Nucl Med. 2001 May;28(5):625-32.

PMID:
11383869
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk